Pharmaceutical products

Contract Value:: -
Notice Type:: Contract award notice

Published Date:: 10 September 2015
Closing Date:

Location(s):: UK UNITED KINGDOM

Description:

Unlicensed compounded medicinal products are purchased to meet the clinical needs of patients for which no licensed medicine is available. Participating Trusts within the East Midlands and Walsall have insufficient capacity to compound sufficient unlicensed medicines to meet their needs, therefore a supplier/supplier(s) are sought who are able to offer a high quality, cost-effective service to supply unlicensed compounded medicines. Trusts will buy the unlicensed compounded medicines to hold as stock, to meet the anticipated future needs of their patients. The unlicensed medicines will, therefore, be required to be batch produced and quality assured. All products must be supplied with a comprehensive Certificate of Analysis and including sterility testing where appropriate. The aim of this tender is to:

— Provide significant improvements in the supply of unlicensed compounded medicinal products, and specifically to achieve optimisation and standardisation of the formulation, presentation and labelling of products to improve safe handling and reduce risks to patients and staff,

— Quality assured products with good shelf lives,

— Approved product specifications to facilitate quality assurance at trust level,

— Reliable and consistent deliveries,

— Competitive pricing,

EMPC, acting on behalf of participating Trusts, reserves the right to award to more than 1 supplier to achieve the aims of this tender.

Awarded to:: Acetic Acid Solution 5 % v/v; Adrenaline 1 in 1000; Topical Chloral Hydrate 125 mg; Suppositories Allopurinol 100 mg in 5 ml Oral Suspension; Glycopyrrolate 0.05 % w/v Solution; Hydroxycarbamide 500 mg in 5 ml Suspension; Mannitol 2.5 % Carob Bean; Colchester Hospital University Hospital NHS Foundation Trust, Essex (); Antacid and Oxetacaine Suspension S/F Chloral Hydrate 500 mg in 5 ml Oral Liquid; Clopidogrel 75 mg in 5 ml; Oral Suspension Frusemide 5 mg in 5 ml Oral Solution S/F; Ketamine 50 mg in 5 ml Oral Solution 300 ml; Phenobarbital 50 mg in 5 ml Oral Suspension; Spironolactone 5 mg in 5 ml Oral Solution S/F; Spironolactone 50 mg in 5 ml Oral Suspension; Colchester Hospital University Hospital NHS Foundation Trust, Essex (); Glycopyrrolate 200 microgram in 1 ml Oral Solution 100 ml; Colchester Hospital University Hospital NHS Foundation Trust, Essex (); Lidocaine 4 % Topical Solution (Colourless); Lidocaine 4 % Topical Solution (Coloured); Sodium Chloride 4 % w/v Nebuliser Solution; Sodium Chloride 5 % w/v Nebuliser Solution; Digoxin 100 microgram/ml Paed Inj; Folic Acid Injection 15 mg /1 ml Injection; Colchester Hospital University Hospital NHS Foundation Trust, Essex (); Omeprazole 10 mg in 5 ml Suspension — 125 ml; Tacrolimus 5 mg in 5 ml —Oral Suspension 60 ml; Colchester Hospital University Hospital NHS Foundation Trust, Essex (); Tranexamic Acid 500 mg in 10 ml Suspension — 300 ml; Colchester Hospital University Hospital NHS Foundation Trust, Essex (); Acetic Acid Solution 5 % v/v; Adrenaline 1 in 1000; Topical Chloral Hydrate 125 mg; Suppositories Allopurinol 100 mg in 5 ml Oral Suspension; Glycopyrrolate 0.05 % w/v Solution; Hydroxycarbamide 500 mg in 5 ml Suspension; Mannitol 2.5 % Carob Bean; Newcastle Hospital NHS Foundation Trust, Tyne and Wear (); Antacid and Oxetacaine Suspension S/F Chloral Hydrate 500 mg in 5 ml Oral Liquid; Clopidogrel 75 mg in 5 ml; Oral Suspension Frusemide 5 mg in 5 ml Oral Solution S/F; Ketamine 50 mg in 5 ml Oral Solution 300 ml; Phenobarbital 50 mg in 5 ml Oral Suspension; Spironolactone 5 mg in 5 ml Oral Solution S/F; Spironolactone 50 mg in 5 ml Oral Suspension; Newcastle Hospital NHS Foundation Trust, Tyne and Wear (); Glycopyrrolate 200 microgram in 1 ml Oral Solution 100 ml; Newcastle Hospital NHS Foundation Trust, Tyne and Wear (); Lidocaine 4 % Topical Solution (Colourless); Lidocaine 4 % Topical Solution (Coloured); Sodium Chloride 4 % w/v Nebuliser Solution; Sodium Chloride 5 % w/v Nebuliser Solution; Digoxin 100 microgram/ml Paed Inj; Folic Acid Injection 15 mg /1 ml Injection; Newcastle Hospital NHS Foundation Trust, Tyne and Wear (); Omeprazole 10 mg in 5 ml Suspension — 125 ml; Tacrolimus 5 mg in 5 ml —Oral Suspension 60 ml; Newcastle Hospital NHS Foundation Trust, Tyne and Wear (); Tranexamic Acid 500 mg in 10 ml Suspension — 300 ml; Newcastle Hospital NHS Foundation Trust, Tyne and Wear (); Acetic Acid Solution 5 % v/v; Adrenaline 1 in 1000; Topical Chloral Hydrate 125 mg; Suppositories Allopurinol 100 mg in 5 ml Oral Suspension; Glycopyrrolate 0.05 % w/v Solution; Hydroxycarbamide 500 mg in 5 ml Suspension; Mannitol 2.5 % Carob Bean; Nova Laboratories Ltd, Wigston (); Antacid and Oxetacaine Suspension S/F Chloral Hydrate 500 mg in 5 ml Oral Liquid; Clopidogrel 75 mg in 5 ml; Oral Suspension Frusemide 5 mg in 5 ml Oral Solution S/F; Ketamine 50 mg in 5 ml Oral Solution 300 ml; Phenobarbital 50 mg in 5 ml Oral Suspension; Spironolactone 5 mg in 5 ml Oral Solution S/F; Spironolactone 50 mg in 5 ml Oral Suspension; Nova Laboratories Ltd, Wigston (); Glycopyrrolate 200 microgram in 1 ml Oral Solution 100 ml; Nova Laboratories Ltd, Wigston (); Lidocaine 4 % Topical Solution (Colourless); Lidocaine 4 % Topical Solution (Coloured); Sodium Chloride 4 % w/v Nebuliser Solution; Sodium Chloride 5 % w/v Nebuliser Solution; Digoxin 100 microgram/ml Paed Inj; Folic Acid Injection 15 mg /1 ml Injection; Nova Laboratories Ltd, Wigston (); Omeprazole 10 mg in 5 ml Suspension — 125 ml; Tacrolimus 5 mg in 5 ml —Oral Suspension 60 ml; Nova Laboratories Ltd, Wigston (); Tranexamic Acid 500 mg in 10 ml Suspension — 300 ml; Nova Laboratories Ltd, Wigston (); Acetic Acid Solution 5 % v/v; Adrenaline 1 in 1000; Topical Chloral Hydrate 125 mg; Suppositories Allopurinol 100 mg in 5 ml Oral Suspension; Glycopyrrolate 0.05 % w/v Solution; Hydroxycarbamide 500 mg in 5 ml Suspension; Mannitol 2.5 % Carob Bean; Rosemont Pharmaceuticals Ltd, Leeds (); Antacid and Oxetacaine Suspension S/F Chloral Hydrate 500 mg in 5 ml Oral Liquid; Clopidogrel 75 mg in 5 ml; Oral Suspension Frusemide 5 mg in 5 ml Oral Solution S/F; Ketamine 50 mg in 5 ml Oral Solution 300 ml; Phenobarbital 50 mg in 5 ml Oral Suspension; Spironolactone 5 mg in 5 ml Oral Solution S/F; Spironolactone 50 mg in 5 ml Oral Suspension; Rosemont Pharmaceuticals Ltd, Leeds (); Glycopyrrolate 200 microgram in 1 ml Oral Solution 100 ml; Rosemont Pharmaceuticals Ltd, Leeds (); Lidocaine 4 % Topical Solution (Colourless); Lidocaine 4 % Topical Solution (Coloured); Sodium Chloride 4 % w/v Nebuliser Solution; Sodium Chloride 5 % w/v Nebuliser Solution; Digoxin 100 microgram/ml Paed Inj; Folic Acid Injection 15 mg /1 ml Injection; Rosemont Pharmaceuticals Ltd, Leeds (); Omeprazole 10 mg in 5 ml Suspension — 125 ml; Tacrolimus 5 mg in 5 ml —Oral Suspension 60 ml; Rosemont Pharmaceuticals Ltd, Leeds (); Tranexamic Acid 500 mg in 10 ml Suspension — 300 ml; Rosemont Pharmaceuticals Ltd, Leeds (); Acetic Acid Solution 5 % v/v; Adrenaline 1 in 1000; Topical Chloral Hydrate 125 mg; Suppositories Allopurinol 100 mg in 5 ml Oral Suspension; Glycopyrrolate 0.05 % w/v Solution; Hydroxycarbamide 500 mg in 5 ml Suspension; Mannitol 2.5 % Carob Bean; Stockport NHS Foundation Trust, Stockport (); Antacid and Oxetacaine Suspension S/F Chloral Hydrate 500 mg in 5 ml Oral Liquid; Clopidogrel 75 mg in 5 ml; Oral Suspension Frusemide 5 mg in 5 ml Oral Solution S/F; Ketamine 50 mg in 5 ml Oral Solution 300 ml; Phenobarbital 50 mg in 5 ml Oral Suspension; Spironolactone 5 mg in 5 ml Oral Solution S/F; Spironolactone 50 mg in 5 ml Oral Suspension; Stockport NHS Foundation Trust, Stockport (); Glycopyrrolate 200 microgram in 1 ml Oral Solution 100 ml; Stockport NHS Foundation Trust, Stockport (); Lidocaine 4 % Topical Solution (Colourless); Lidocaine 4 % Topical Solution (Coloured); Sodium Chloride 4 % w/v Nebuliser Solution; Sodium Chloride 5 % w/v Nebuliser Solution; Digoxin 100 microgram/ml Paed Inj; Folic Acid Injection 15 mg /1 ml Injection; Stockport NHS Foundation Trust, Stockport (); Omeprazole 10 mg in 5 ml Suspension — 125 ml; Tacrolimus 5 mg in 5 ml —Oral Suspension 60 ml; Stockport NHS Foundation Trust, Stockport (); Tranexamic Acid 500 mg in 10 ml Suspension — 300 ml; Stockport NHS Foundation Trust, Stockport (); Acetic Acid Solution 5 % v/v; Adrenaline 1 in 1000; Topical Chloral Hydrate 125 mg; Suppositories Allopurinol 100 mg in 5 ml Oral Suspension; Glycopyrrolate 0.05 % w/v Solution; Hydroxycarbamide 500 mg in 5 ml Suspension; Mannitol 2.5 % Carob Bean; The Specials Laboratory Limited, (); Antacid and Oxetacaine Suspension S/F Chloral Hydrate 500 mg in 5 ml Oral Liquid; Clopidogrel 75 mg in 5 ml; Oral Suspension Frusemide 5 mg in 5 ml Oral Solution S/F; Ketamine 50 mg in 5 ml Oral Solution 300 ml; Phenobarbital 50 mg in 5 ml Oral Suspension; Spironolactone 5 mg in 5 ml Oral Solution S/F; Spironolactone 50 mg in 5 ml Oral Suspension; The Specials Laboratory Limited, (); Glycopyrrolate 200 microgram in 1 ml Oral Solution 100 ml; The Specials Laboratory Limited, (); Lidocaine 4 % Topical Solution (Colourless); Lidocaine 4 % Topical Solution (Coloured); Sodium Chloride 4 % w/v Nebuliser Solution; Sodium Chloride 5 % w/v Nebuliser Solution; Digoxin 100 microgram/ml Paed Inj; Folic Acid Injection 15 mg /1 ml Injection; The Specials Laboratory Limited, (); Omeprazole 10 mg in 5 ml Suspension — 125 ml; Tacrolimus 5 mg in 5 ml —Oral Suspension 60 ml; The Specials Laboratory Limited, (); Tranexamic Acid 500 mg in 10 ml Suspension — 300 ml; The Specials Laboratory Limited, ()

: Download full details as .pdf

The Buyer:: East Midlands Procurement Portal

CPV Code(s):: 33600000 - Pharmaceutical products